These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4620093)

  • 1. Dominant inherited familial factor VIII deficiency (Von Willebrand disease) associated with thrombocytopathic thrombocytopaenia. (Biologic and genetic implications).
    Sultan Y; Bernal-Hoyos EJ; Levy-Toledano S; Jeanneau C; Caen JP
    Pathol Biol (Paris); 1974 Nov; 22 suppl():27-36. PubMed ID: 4620093
    [No Abstract]   [Full Text] [Related]  

  • 2. Canine von Willebrand's disease.
    Dodds WJ
    J Lab Clin Med; 1970 Nov; 76(5):713-21. PubMed ID: 5312238
    [No Abstract]   [Full Text] [Related]  

  • 3. Von Willebrand's disease with thrombocytopenia, platelet function defect, and an abnormal Factor VIII molecule.
    Arkel YS; Desposito F
    Am J Pediatr Hematol Oncol; 1982; 4(3):249-57. PubMed ID: 6816083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factor VIII in hemophilia and von Willebrand's disease].
    Bolland J; Lambotte C
    Rev Med Liege; 1978 Apr; 33(8):284-95. PubMed ID: 349657
    [No Abstract]   [Full Text] [Related]  

  • 5. NIH conference. Factor VIII.
    Ann Intern Med; 1977 May; 86(5):598-616. PubMed ID: 300583
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ristocetin-induced platelet aggregation in von Willebrand's disease, thrombasthenia and essential athrombia with special reference to AHF-like antigen (author's transl)].
    Ishiguro J; Kondo M; Ogata K; Takahashi T; Kamiya T
    Rinsho Ketsueki; 1975 Jul; 16(7):716-24. PubMed ID: 1080812
    [No Abstract]   [Full Text] [Related]  

  • 7. [Importance of the study of the binding of factor VIII to von Willebrand factor in hemophilia A].
    Batlle J; Blanco-López MJ; Castiñeira MP; López-Fernández MF
    Sangre (Barc); 1992 Jun; 37(3):211-24. PubMed ID: 1359656
    [No Abstract]   [Full Text] [Related]  

  • 8. [The factor VIII complex: hemophilia A and von Willebrand disease (author's transl)].
    Tobelem G; Rothschild C
    Ann Pediatr (Paris); 1982 Feb; 29(2):95-9. PubMed ID: 6800297
    [No Abstract]   [Full Text] [Related]  

  • 9. A 1973 look at hemophilia and von Willebrand's disease.
    Ratnoff OD
    Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
    [No Abstract]   [Full Text] [Related]  

  • 10. Familial occurrence of von Willebrand's disease, thrombocytopenia, and severe gastrointestinal bleeding.
    Corder MP; Culp NW; Barrett O
    Am J Med Sci; 1973 Mar; 265(3):219-23. PubMed ID: 4540781
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies of a large family with von Willebrand-Jürgens syndrome].
    Walther C
    Z Gesamte Inn Med; 1967 May; 22(9):268-71. PubMed ID: 5301933
    [No Abstract]   [Full Text] [Related]  

  • 12. Variants of von Willebrand's disease. Analysis of 55 cases.
    Chen Z; Wang ZY; Chen SR; Wang DF; Zhang YM; Wang HL
    Chin Med J (Engl); 1984 Mar; 97(3):151-4. PubMed ID: 6432476
    [No Abstract]   [Full Text] [Related]  

  • 13. [Measurement of platelet adhesiveness using a modified form of the Hellem II method with special reference to Von Willebrand-Jürgens syndrome].
    Niessner H
    Thromb Diath Haemorrh; 1972 Jul; 27(3):434-51. PubMed ID: 4541210
    [No Abstract]   [Full Text] [Related]  

  • 14. von Willebrand disease masquerading as haemophilia A.
    Mazurier C
    Thromb Haemost; 1992 Apr; 67(4):391-6. PubMed ID: 1631785
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemophilia and von Willebrand's disease: genetic considerations.
    Green D
    Ann Clin Lab Sci; 1980; 10(2):123-7. PubMed ID: 6770741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The factor VIII complex: hemophilia A and von Willebrand disease].
    Tobelem G; Rothschild C
    Sem Hop; 1982 Sep; 58(35):2032-6. PubMed ID: 6293093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand disease associated with familial thrombocytopenia and increased ristocetin-induced platelet aggregation.
    Takahashi H; Nagayama R; Hattori A; Ihzumi T; Tsukada T; Shibata A
    Am J Hematol; 1981; 10(1):89-99. PubMed ID: 6789673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII competitive enzyme assay: observations in von Willebrand's variants and hemophiliacs.
    Yorde LD; Yorde DE; Sasse EA; Hussey CV
    Clin Physiol Biochem; 1984; 2(6):298-303. PubMed ID: 6440727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
    Eikenboom JC; Castaman G; Kamphuisen PW; Rosendaal FR; Bertina RM
    Thromb Haemost; 2002 Feb; 87(2):252-7. PubMed ID: 11859851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recommended protocol for the study of the ex vivo biological effects of virus-inactivated plasma concentrates in patients with von Willebrand disease. The von Willebrand Factor Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis and of the von Willebrand Disease Committee of the World Federation of Hemophilia.
    Mannucci PM
    Thromb Haemost; 1992 Jul; 68(1):84-7. PubMed ID: 1514179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.